Quantcast

Latest Pharmaceuticals policy Stories

2014-07-31 20:23:09

2015 Part D Premiums Show Competition, Home Delivery, Choice Deliver Satisfaction and Savings WASHINGTON, July 31, 2014 /PRNewswire-USNewswire/ -- According to data released today by the Centers for Medicare & Medicaid Services, the 2015 average monthly Medicare Part D premium is expected to remain stable at $32, a figure far lower than was originally projected, the Pharmaceutical Care Management Association (PCMA) said. "The popular Part D program continues to be a bright spot...

2014-07-31 16:28:25

ATLANTA, July 31, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the Danish Health and Medicines Authority has granted marketing authorization to ILUVIEN® for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available...

2014-07-31 16:28:08

SARASOTA, Fla., July 31, 2014 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI) announced today that it has initiated the development of its lead molecule, Anatabine Citrate, in Europe; and that it has selected Quotient Clinical, The Translational Pharmaceutics Company, based in the United Kingdom (UK) to run its early development programs. http://photos.prnewswire.com/prnvar/20140731/132375 The Company expects to file a Clinical Trial Application (CTA) by the end of...

2014-07-31 16:27:58

Commercial Opportunities and Hurdles Discussed in New Decision Resources Group Executive Briefing BURLINGTON, Mass., July 31, 2014 /PRNewswire/ -- Decision Resources Group's experts are scoping healthcare funding changes brought about by the Affordable Care Act (ACA), which has affected both reimbursement and prescribing of pharmaceutical therapies. The ACA altered how Managed Care Organizations (MCOs) cover beneficiaries through new regulations and expanded access via government-supported...

2014-07-31 12:29:57

As Pharmaceutical Companies Seek to Add Value to Their Products through Patient Support Tools, P&T Committees Show Substantial Interest in Add-Ons BURLINGTON, Mass., July 31, 2014 /PRNewswire/ -- A substantial share of pharmacy and therapeutics (P&T) committee members--who make decisions about which therapies are included in formularies--say patient support resources from pharma influence formulary placement, according to a new Manhattan Research study, Taking the Pulse® Formulary...

2014-07-31 08:37:16

ANTWERP, Belgium and LONDON, July 31, 2014 /PRNewswire/ -- genae, a global Contract Research Organization (CRO) and services provider for the medical industries, announced today the incorporation of genae UK in London. The United Kingdom has one of the largest medical device markets in the world. It was valued at USD 8.9 billion in 2012 and it is projected to increase by a CAGR of 6.0% until 2017. Health expenditure was estimated at USD 234 billion in 2012, equal to...

2014-07-30 08:33:57

Former Cardinal Health Manager Brings Expertise to Optimize Company's Role at the Forefront of Big Business LOS ANGELES, July 30, 2014 /PRNewswire/ -- The MedMen, the first and leading consulting and management firm in the marijuana industry, is proud to announce the appointment of Dr. Duke Fu as President of the company after leaving behind five years of indispensable experience as a Manager in Nuclear Pharmaceutical division of Cardinal Health, ranked 19(th) on the Fortune 500...

2014-07-30 08:33:18

DUBLIN, July 30, 2014 /PRNewswire/ -- Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application for desoximetasone topical spray 0.25% and that it has notified Taro Pharmaceuticals U.S.A., Inc., the owner of the Reference Listed Drug of its filing. http://photos.prnewswire.com/prnvar/20120301/DE62255LOGO On July 28, 2014, Taro filed suit against Perrigo in the United States District Court for...

2014-07-29 23:05:06

MarketReportsOnline.com adds "Latest Guidebook for Conducting Pharma Clinical Trials in China: From Regulations to Practice (2014 Edition)" report to its research store. Dallas, Texas (PRWEB) July 29, 2014 This Latest Guidebook for Conducting Pharma Clinical Trials in China: From Regulations to Practice (2014 Edition) not only provided a comprehensive and thorough knowledge of the latest Chinese regulations on clinical trials for imported drug registration but also introduced...

2014-07-29 12:36:01

WASHINGTON, July 29, 2014 /PRNewswire-USNewswire/ -- New high priced hepatitis C drugs will increase federal spending in Medicare Part D by a projected $2.9 to $5.8 billion next year, according to a new report by the actuarial firm Milliman released today by the Pharmaceutical Care Management Association (PCMA). Milliman projects that average Part D premiums could increase by as much as 8.6 percent in 2015 as a result of high-priced hepatitis C drugs, including Sovaldi and Olysio. The study...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related